CNY 21.81
(0.83%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 192.01 Million | 54 Million | 36.32 Million | 124.99 Million | 67.04 Million | 25.65 Million |
Net Income | 165.62 Million | 128.06 Million | 116.08 Million | 106.71 Million | 104.53 Million | 88.65 Million |
Depreciation & Amortization | 13.99 Million | 11.54 Million | 9.5 Million | 8.64 Million | 6.76 Million | 7.94 Million |
Deferred income taxes | -3.56 Million | -4.8 Million | -230.93 Thousand | -900.09 Thousand | -42.9 Thousand | -760 Thousand |
Stock-based compensation | 15.1 Million | 5.18 Million | - | - | - | - |
Change in working capital | -11.19 Million | -98.79 Million | -87.66 Million | 1.38 Million | -54.04 Million | -79.9 Million |
Other non-cash items | 69.96 Million | 10.69 Million | -1.59 Million | 8.24 Million | 9.79 Million | 8.95 Million |
Investing Cash Flow | 150.96 Million | 68.42 Million | -364.24 Million | -22.85 Million | -12.21 Million | -1.76 Million |
Investments in PPE | -57.3 Million | -18.17 Million | -17.48 Million | -22.85 Million | -12.21 Million | -1.78 Million |
Acquisitions | 14 Million | 858.6 Thousand | 346.75 Million | - | - | 18 Thousand |
Investment purchases | - | -146.11 Million | -351.25 Million | - | - | - |
Sales/Maturities of investments | 194.26 Million | 232.7 Million | 4.49 Million | - | - | - |
Other Investing Activities | 198.21 Million | -858.59 Thousand | -346.75 Million | -22.85 Million | -12.21 Million | 18 Thousand |
Financing Cash Flow | -45.03 Million | -24.89 Million | 399.92 Million | -82.78 Million | -18.12 Million | -26.61 Million |
Debt repayment | -7.33 Million | -20 Million | -20 Million | -20 Million | -20 Million | -60 Million |
Dividends payments | -55.98 Million | -55.98 Million | -41.98 Million | -41.98 Million | -8.52 Million | -6.61 Million |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | -14.13 Million | - | - | - |
Other Financing Activities | 18.28 Million | 29.86 Million | 425.93 Million | -19.9 Million | 10.4 Million | 40 Million |
Accounts receivables | -96.57 Million | -353.97 Million | -150.77 Million | -141.09 Million | -115.58 Million | -125.71 Million |
Accounts payables | 179.32 Million | 407.32 Million | 99.76 Million | 150.85 Million | 80.84 Million | 85.19 Million |
Inventory | -97.57 Million | -147.34 Million | -36.42 Million | -7.46 Million | -19.26 Million | -38.61 Million |
Other working capital | 3.63 Million | -4.8 Million | -230.93 Thousand | -900.09 Thousand | -42.9 Thousand | -41.28 Million |
Cash at beginning of period | 414.82 Million | 187.06 Million | 115.05 Million | 95.69 Million | 58.99 Million | 61.71 Million |
Cash at end of period | 691.94 Million | 284.59 Million | 187.06 Million | 115.05 Million | 95.69 Million | 58.99 Million |
Capital Expenditure | -57.3 Million | -18.17 Million | -17.48 Million | -22.85 Million | -12.21 Million | -1.78 Million |
Effect of forex changes on cash | - | 0.91 | - | - | -0.87 | 0.51 |
Net cash flow / Change in cash | 277.11 Million | 97.52 Million | 72 Million | 19.36 Million | 36.7 Million | -2.72 Million |
Free Cash Flow | 134.7 Million | 35.82 Million | 18.84 Million | 102.14 Million | 54.82 Million | 23.87 Million |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | - | 36.34 Million | 39.47 Million | 165.62 Million | 46.69 Million | 40.81 Million |
Depreciation & Amortization | - | 3.48 Million | 3.48 Million | 13.99 Million | 3.59 Million | -5.99 Million |
Deferred income taxes | - | -261.95 Thousand | - | -3.56 Million | - | -41.59 Million |
Stock-based compensation | - | 5.22 Million | - | 15.1 Million | 15.1 Million | -5.16 Million |
Change in working capital | - | -37.39 Million | - | -11.19 Million | -175.41 Million | 52.75 Million |
Other non-cash items | - | 143.28 Thousand | -124.9 Million | 69.96 Million | 184.64 Million | 19.8 Million |
Investing Cash Flow | -2.18 Million | 38.58 Million | 4.37 Million | 150.96 Million | 5.39 Million | 41.3 Million |
Investments in PPE | -2.4 Million | -3 Million | -5.62 Million | -57.3 Million | -8.21 Million | -5.58 Million |
Acquisitions | - | - | - | 14 Million | - | 1255.00 |
Investment purchases | - | - | - | - | - | 30 Million |
Sales/Maturities of investments | 221.25 Thousand | 41.58 Million | 10 Million | 194.26 Million | 13.6 Million | 16.89 Million |
Other Investing Activities | - | 41.58 Million | 10.37 Million | 198.21 Million | 13.55 Million | -0.28 |
Financing Cash Flow | -13.79 Million | -44.87 Million | - | -45.03 Million | 1.63 Million | -3.05 Million |
Debt repayment | - | -1.66 Million | - | -7.33 Million | -1.66 Million | - |
Dividends payments | -13.62 Million | -43.21 Million | - | -55.98 Million | -55.98 Million | -3.05 Million |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -172.12 Thousand | -43.21 Million | - | 18.28 Million | 55.95 Million | -3.05 Million |
Accounts receivables | - | -18.37 Million | - | -96.57 Million | -96.57 Million | 31.99 Million |
Accounts payables | - | - | - | 179.32 Million | - | 7.55 Million |
Inventory | - | -26.19 Million | - | -97.57 Million | -97.57 Million | 20.76 Million |
Other working capital | - | 7.16 Million | - | 3.63 Million | 18.73 Million | -7.55 Million |
Cash at beginning of period | 527.57 Million | 501.47 Million | 691.94 Million | 414.82 Million | 527.98 Million | 249.78 Million |
Cash at end of period | 608.9 Million | 527.57 Million | 561.1 Million | 691.94 Million | 691.94 Million | 347.76 Million |
Capital Expenditure | -2.4 Million | -3 Million | -5.62 Million | -57.3 Million | -8.21 Million | -5.58 Million |
Effect of forex changes on cash | - | - | - | - | - | -892.82 Thousand |
Net cash flow / Change in cash | 81.33 Million | 26.09 Million | -130.84 Million | 277.11 Million | 163.95 Million | 97.97 Million |
Free Cash Flow | -2.4 Million | 29.73 Million | -91.05 Million | 134.7 Million | 219.53 Million | 55.03 Million |
0RV4
NSRGY
LIT
MMWL
DDS
3641